Scancell Holdings PLC - developer of novel immunotherapies for the treatment of cancer and infectious disease - Close associate of Non-Executive Director Martin Diggle sells 400,000 shares at an aggregate price of 27.25 pence per share, worth GBP109,000.
Current stock price: 24.50p; down 115 on Friday
Year-to-date change: up 75%
By Anna Farley; firstname.lastname@example.org
Copyright 2021 Alliance News Limited. All Rights Reserved.